BioCentury
ARTICLE | Clinical News

PGX-100: Start Phase I

February 14, 2005 8:00 AM UTC

ParinGenix will begin this month a placebo-controlled, dose-escalation, U.S. Phase I trial. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article